Optimi Health Corp OPTH

$3.33 -0.05 (-1.48%)

Valuation

Market cap
19,354,000
Revenue TTM
$300,000
Net income TTM
$-2,650,000
PE ratio
0.00
Forward PE
—
Profit margin
-883.33%
Debt to equity
0.97

Trading

Volume
18,345
Avg volume
43,222
Day's range
$3.25 – $3.74
Shares out
5,726,000
Stochastic %K
28%
Beta
—
Analysts
Hold
Price target
$10.80

Price

Company profile

Optimi Health Corp. operates as a pharmaceutical and nutraceutical drug manufacturing company in Canada. The company manufactures controlled substances including finished MDMA and psilocybin drug products, supplying them directly to authorized clinics, pharmacies, clinical trials, and partners. The company produces and supplies MDMA, natural psilocybin, psilocin, other psychedelic substances, and functional mushrooms...

Show more

Optimi Health Corp. operates as a pharmaceutical and nutraceutical drug manufacturing company in Canada. The company manufactures controlled substances including finished MDMA and psilocybin drug products, supplying them directly to authorized clinics, pharmacies, clinical trials, and partners. The company produces and supplies MDMA, natural psilocybin, psilocin, other psychedelic substances, and functional mushrooms derived from botanical sources for health and wellness markets. The company also engages in farming, processing, and distribution of raw mushroom biomass, mushroom extracts, manufacturing of drug products, and mushroom supplements. It sells its products through Amazon marketplace and distributors/brokers, as well as online. Optimi Health Corp. was incorporated in 2020 and is based in Princeton, Canada.

Industry
Drug Manufacturers - Specialty & Generic
Sector
Healthcare
Phone
778-761-4551
Website
https://www.optimihealth.ca
Address
269 David Brown Way, Princeton, Canada

Latest news

Stocktwits

CoffeeRocks Oct 19, 2:31 PM
$OPTH $OPTI.CSE $SRXH OPTI has Melanie Pump as CEO 20$ 🎯 here
0 replies
LurkerLongtime Oct 17, 9:58 PM
$OPTH $STIM $PSIL
0 replies
GodBlessGold Oct 14, 3:17 PM
$OPTH so obviously someone or group is plummeting this stock ahead of the investor meeting tomorrow.
1 replies
LurkerLongtime Oct 12, 7:48 PM
$OPTH ok fine I'll buy more
0 replies
GodBlessGold Oct 12, 7:27 PM
$OPTH no news and she gets blasted
0 replies
GodBlessGold Oct 12, 2:41 PM
$OPTH oi oi oi
0 replies
GodBlessGold Oct 6, 5:50 PM
$OPTH bruh
0 replies
JTE_Theta Sep 30, 4:31 PM
🚨 $OPTH | PSYCHEDELICS WITH REVENUE ! Optimi Health is one of the few psychedelic names already generating sales. Psilocybin + MDMA capsules sold under Australia's Authorized Prescriber Scheme • Health Canada GMP + export licences • Psilocybin supplied for a UK Phase 2 trial $15M raised on 2026 Nasdaq uplisting • Pipeline: Phase 2 psilocybin: up to 200 MDD patients •Phase 3 MDMA: up to 100 PTSD patients •Enrolment targeted for 2027 New Chief Clinical Development Officer (Dr. Michael Blough) + Melanie Pump joins the Board. CommunicatedDisclaimer:http://stockresearchtoday.com/opth/
0 replies